The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
FDA Approves Dyloject Injection for Pain Management
December 30th 2014The FDA today approved Hospira Inc's diclofenac sodium injection, a proprietary nonsteroidal anti-inflammatory drug analgesic, for the treatment of mild to moderate pain or for the management of moderate to severe pain alone or in combination with opioid analgesics among adults.
Read More
At a special meeting of shareholders held today, Walgreens shareholders voted to approve all proposals related to the company's acquisition of the remaining 55 percent of Alliance Boots GmbH that it does not currently own and the reorganization of the company into a holding company structure.
Read More
Baxter Submits Application for FDA Approval of Von Willebrand Disease Treatment
December 29th 2014Baxter International Inc has submitted a biologics license application to the FDA for the approval of BAX111, the first highly purified recombinant von Willebrand factor in clinical development as a treatment for von Willebrand disease.
Read More
Adherence Issues with Antidepressants in Bipolar Patients
December 25th 2014Bipolar patients are among the most difficult to treat, in part because mania is alluring and in part because they are often poor historians. As with any patient who must take medication for a chronic condition, bipolar patients' adherence rates generally decline over time. About two-thirds of bipolar patients take more than 1 medication for this condition, and an antidepressant is often one component of the drug regimen.
Read More